Skip to main content

Intralesional Collagenase Injection

  • Chapter
  • First Online:
Atlas of Office Based Andrology Procedures

Abstract

Collagenase clostridium histolyticum (Xiaflex®) is an enzyme, which acts to breakdown the collagenous Peyronie’s plaque. This enzyme is injected directly into the Peyronie’s plaque. The injection technique takes less than 2 min in duration. Bleeding complications (ecchymosis, hematoma formation) and penile fracture (corporal rupture) are the main complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Auxillium Pharmaceuticals, Inc. Xiaflex—Collagenase clostridium histolyticum, Full Prescribing Information.

    Google Scholar 

  • Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199–207.

    Article  CAS  PubMed  Google Scholar 

  • Hellstrom WJ, Feldman RA, Coyne KS, Kaufman GJ, Smith TM, Tursi JP, et al. Self-report and clinical response to Peyronie’s disease treatment: Peyronie’s disease questionnaire results from 2 large double-blind, randomized, placebo-controlled phase 3 studies. Urology. 2015;86(2):291–8.

    Article  PubMed  Google Scholar 

  • Jordan GH, Carson CC, Lipshultz LI. Minimally invasive treatment of Peyronie’s disease: evidence-based progress. BJU Int. 2014;114(1):16–24.

    Article  PubMed  Google Scholar 

  • Levine LA, Cuzin B, Mark S, Gelbard MK, Jones NA, Liu G, et al. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie’s disease: a phase 3 open-label study. J Sex Med. 2015;12(1):248–58.

    Article  PubMed  Google Scholar 

  • Lipshultz LI, Goldstein I, Seftel AD, Kaufman GJ, Smith TM, Tursi JP, et al. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie’s disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies. BJU Int. 2015;116(4):650–6.

    Article  CAS  PubMed  Google Scholar 

  • Peak TC, Mitchell GC, Yafi FA, Hellstrom WJ. Role of collagenase clostridium histolyticum in Peyronie’s disease. Biologics. 2015;9:107–16.

    PubMed  PubMed Central  Google Scholar 

  • Ziegelmann MJ, Viers BR, McAlvany KL, Bailey GC, Savage JB, Trost LW. Restoration of penile function and patient satisfaction with intralesional collagenase clostridium histolyticum injection for Peyronie’s disease. J Urol. 2016;195(4P1):1051–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John P. Mulhall MD, MSc, FECSM, FACS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mulhall, J.P., Jenkins, L.C. (2017). Intralesional Collagenase Injection. In: Mulhall, J., Jenkins, L. (eds) Atlas of Office Based Andrology Procedures. Springer, Cham. https://doi.org/10.1007/978-3-319-42178-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42178-0_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42176-6

  • Online ISBN: 978-3-319-42178-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics